×
<- Back

Pulmonary hypertension: drug treatments

Speciality Classification
Pharmacists
Location
Online
Delivery
Online
Duration
1.5 hours
Provider
Pharmaceutical Society of Australia

Acute pain management explained

AJP - June 2021 - Disease state management

Pulmonary hypertension can be a devastating disease that is easily missed in the early stages because of its typically nonspecific presentation with gradually increasing dyspnoea. Early diagnosis and treatment are key to improving functional and haemodynamic outcomes and survival. With advances in management, most forms of pulmonary hypertension are treatable.

Learning Objectives

After completing this activity, pharmacists should be able to:

  • describe the symptoms and signs of pulmonary hypertension;
  • list the classification of pulmonary hypertension;
  • discuss the main causes of pulmonary hypertension;
  • discuss the pharmacological treatments for pulmonary hypertension;
  • counsel people about the management of pulmonary hypertension.

CPD Credits

Accreditation Code: CX21029

Group 1:1.50

Group 2:3.00

This activity has been accredited for 1.5 hours of Group 1 CPD (or 1.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1.5 hours of Group 2 CPD (or 3 CPD credits) upon successful completion of relevant assessment activities.

Delivery
Title
Pulmonary hypertension: drug treatments
Speciality Classification
Location
Provider Type
Education Provider
Duration
1.5 hours
CPD Points
Group 1 CPD (or 1.5 CPD credits) ; Group 2 CPD (or 3 CPD credits)
Price
Free
Price Details
Free for Members
Location
Online
Price:
Free
Free for Members
Similar Listings
HealthcareLink